α-Methylacyl-CoA racemase: Expression levels of this novel cancer biomarker depend on tumor differentiation

American Journal of Pathology

Volumn 161, Issue 3, 2002, Pages 841-848

  Kuefer, Rainer ^a,b   Varambally, Sooryanarayana ^a   Zhou, Ming ^a   Lucas, Peter C ^a   Loeffler, Martin ^b   Wolter, Hubertus ^b   Mattfeldt, Torsten ^b   Hautmann, Richard E ^b   Gschwend, Juergen E ^b   Barrette, Terrence R ^a   Dunn, Rodney L ^a   Chinnaiyan, Arul M ^a   Rubin, Mark A ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF ULM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

2 METHYLACYL COENZYME A RACEMASE; ACYL COENZYME A; BIOLOGICAL MARKER; PROSTATE SPECIFIC ANTIGEN; RACEMASE; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; CANCER CELL; CELL DIFFERENTIATION; COLORECTAL CANCER; FATTY ACID OXIDATION; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RECEPTOR DOWN REGULATION; RECEPTOR UPREGULATION; SAMPLING; TUMOR DIFFERENTIATION;

EID: 0036731874     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)64244-7     Document Type: Article

References (28)

1. Analysis of recent trends in prostate cancer incidence and mortality
2. Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: Results of a multicenter clinical trial of 6,630 men
3. Cancer surveillance series: Interpreting trends in prostate cancer-part III: Quantifying the link between population prostate-specific antigen testing and recent declines in prostate cancer mortality
4. European randomized study of prostate cancer screening: First-year results of the finnish trial
5. Evaluation of the digital rectal examination as a screening test for prostate cancer. Rotterdam section of the European Randomized Study of Screening for Prostate Cancer
6. Delineation of prognostic biomarkers in prostate cancer
7. Expression profiling reveals hepsin overexpression in prostate cancer
8. Analysis of gene expression identifies candidate markers and pharmacological targets in prostate cancer
9. Molecular genetic profiling of Gleason grade 4/5 prostate cancers compared to benign prostatic hyperplasia
10. Human prostate cancer and benign prostatic hyperplasia: Molecular dissection by gene expression profiling
11. Subcellular localization and physiological role of alpha-methylacyl-CoA racemase
12. In mouse alpha-methylacyl-CoA racemase, the same gene product is simultaneously located in mitochondria and peroxisomes
13. P504S: A new molecular marker for the detection of prostate carcinoma
14. Alpha-methylacyl coenzyme A racemase as a tissue biomarker for prostate cancer
15. Alpha-methylacyl-CoA racemase: A new molecular marker for prostate cancer
16. Rapid ("warm") autopsy study for procurement of metastatic prostate cancer
17. Relational database structure to manage high-density tissue microarray data and images for pathology studies focusing on clinical outcome: The prostate specialized program of research excellence model
18. Loss of CDX2 expression and microsatellite instability are prominent features of large cell minimally differentiated carcinomas of the colon
19. Androgen responsive adult human prostatic epithelial cell lines immortalized by human papillomavirus 18 Carcinogenesis
20. Alpha-methyl-CoA racemase: A novel tumor marker over expressed in several human cancers and their precursor lesions
21. Deciding on radiation therapy for prostate cancer: The physician's perspective
22. Long-term biochemical disease-free and cancer-specific survival following anatomic radical retropubic prostatectomy. The 15-year Johns Hopkins experience
23. Therapeutic options in locally defined or advanced prostate cancer
24. Plasma analysis of di- and trihydroxycholestanoic acid diastereoisomers in peroxisomal alpha-methylacyl-CoA racemase deficiency
25. Dietary polyunsaturated fatty acids and cancers of the breast and colorectum: Emerging evidence for their role as risk modifiers
26. Fat reduction to prevent prostate cancer: Waiting for more evidence?
27. Diet and cancer
28. Purification and characterization of an alpha-methylacyl-CoA racemase from human liver